Error in Author’s Name | Oncology | JAMA Oncology | JAMA Network
[Skip to Navigation]
Sign In
Views 502
Citations 0
Correction
October 10, 2019

Error in Author’s Name

JAMA Oncol. 2019;5(11):1643. doi:10.1001/jamaoncol.2019.4781

In the article titled “Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial,”1 published online September 5, 2019, the wrong initial was used for Dr Harding’s middle name. Dr Harding’s correct name is James J. Harding, MD. This article has been corrected online.

References
1.
Abou-Afa  GK, Shi  Q, Knox  J.  Assessment of treatment with sorafenib plus doxorubicin vs sorafenib alone in patients with advanced hepatocellular carcinoma: phase 3 CALGB 80802 randomized clinical trial  [published online September 5, 2019].  JAMA Oncol. doi:10.1001/jamaoncol.2019.2792Google Scholar
×